EBM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chessman, A. W
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chessman, A. W
Topic Collections
Right arrow EBM Diagnosis
Evidence-Based Medicine 2004; 9:56
© 2004 BMJ Publishing Group Ltd.


Diagnosis

A 3 item screening instrument had moderate sensitivity and specificity for detecting migraine headaches

Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: The ID Migraine(TM) validation study. Neurology 2003;61:375–82.[Abstract/Free Full Text]

Q In an outpatient primary care setting, what is the accuracy of a brief screening instrument (developed from the International Headache Society [IHS] criteria for migraine) that uses self report for detecting migraine headaches?

Clinical impact ratings GP/FP/Primary care ******{star}

Key Words: migraine • mass screening

The first 150 words of the full text of this article appear below.

METHODS
Design: blinded comparison of a 3 item migraine screening tool with a diagnosis of migraine headache made by headache experts.

Setting: 27 primary care practices and 12 headache speciality practice sites in the US.

Patients: 451 patients 18–55 years of age (mean age 39 y, 76% women) who presented for routine primary care appointments and reported >=2 headaches in the past 3 months. Exclusion criteria included inability to read and write English, previous diagnosis of migraine, and participation in a previous Pfizer sponsored migraine study.

Description of test: initially, patients completed a 9 item migraine screener—a self rated paper and pencil questionnaire developed by a consensus panel and based on IHS criteria for migraine headaches. An item reduction process using logistic regression to assess the associations between a response to a screening item and the diagnostic standard resulted in a brief 3 item screener consisting of nausea, photophobia, and headache . . . [Full text of this article]

Alexander W Chessman, MD

Medical University of South Carolina
Charleston, South Carolina, USA







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 by the BMJ Publishing Group Ltd.